TLR4 and COVID-19: Similarly, for COVID-19, TLR4 triggers an excessive inflammatory response, exacerbating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spiking protein-mediated lung injury, thereby deteriorating COVID-19.